skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


This content will become publicly available on February 11, 2026

Title: Long-Term Cell-Membrane-Coated Ultrabright Nanospheres for Targeted Cancer Cell Imaging and Hydrophobic Drug Delivery
Nanoparticle-based imaging agents have gained massive attention for the targeted imaging of early-stage cancer. Among these, organic dye-entrapped/assembled nanoparticles have been recognized as potential imaging agents. However, they are limited by poor brightness, low stability, low reproducibil-ity and scalability, and selective surface engineering, which limits their translational potential. The mo-lecular assembly of amphiphilic precursor molecules and the chosen fluorophore can augment the brightness and stability of engineered nanoimaging agents. Herein, we describe an original engineering method for cancer cell membrane-covered ICG-cellulose acetate nanospheres (180 nm) as biomimetic ultra-bright nanoimaging agents for cancer cell imaging. The targeted cancer cell imaging is compared with folic acid-attached ICG-cellulose acetate nanospheres. Encapsulation of fluorescent organic mole-cules (660 dye molecules/ per nanoparticle) in the core of a polymeric network enhances the overall brightness and long-term photostability due to the entrapment of the loaded fluorescent cargo and poor permeation of oxygen to oxidize the dye. The amphiphilic nature of the selected polymeric network accommodates both hydrophilic and hydrophobic cargo molecules (e.g., imaging and therapeutics). The engineered fluorescent nanoparticles exhibited high brightness (780-980 MESF), uniform particle size distribution (180-240 nm), high stability (tested up to 90 days), good biocompatibility with normal cells (95 %), and high scalability (600 mL/batch). For targeted chemotherapeutics, DOX-loaded bio-mimetic nanoparticles demonstrate better chemotherapeutic response (more than 95 % cancer cell death) than folic acid-attached DOX-loaded nanoparticles (78 % cancer cell death) as identified with 24 h MTT assay. The engineered nanoparticles exhibited cancer cell imaging and therapeutics capabili-ties by delivering imaging and drug molecules in cancer mimicked environment in vitro. Our findings suggest that the engineered nanoparticles not only overcome the limitations of nano-imaging but also provide additional advantages for targeted cancer therapeutics.  more » « less
Award ID(s):
2110757 1911253
PAR ID:
10581377
Author(s) / Creator(s):
; ; ; ; ; ; ;
Publisher / Repository:
ACS
Date Published:
Journal Name:
Chemistry of Materials
Volume:
37
Issue:
3
ISSN:
0897-4756
Page Range / eLocation ID:
845 to 856
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Abstract Photothermal reagents sensitive to near‐infrared (NIR) light are promising imaging agents and therapeutics for anticancer applications because of the deep tissue penetration of NIR light, allowing for spatiotemporal control over the therapeutic activity, with minimal damage to normal tissues. Herein, a new class of NIR‐sensitive biopolymer‐based nanoparticles is presented by covalently conjugating indocyanine green (ICG) onto the surface of naturally occurring glycogen nanoparticles. The resulting ICG‐glycogen conjugates exhibit a markedly enhanced aqueous stability in comparison to free ICG molecules. Furthermore, an efficient light‐to‐heat conversion is enabled by ICG‐glycogen conjugates, as evidenced by the elevated temperatures of their aqueous solutions upon exposure to NIR light. Critically, ICG‐glycogen conjugates are capable of cell internalization, and under NIR irradiation the effective eradication of breast cancer cells, demonstrating their potential in photothermal therapy for cancer. 
    more » « less
  2. pH-responsive polymeric nanoparticles are an exciting class of stimuli-responsive materials that can respond to changes in pH and, as a result, have been developed for numerous applications in biomedicine, such as the loading and delivery of various cargoes. One common transformation is nanoparticle swelling due to the protonation or deprotonation of specific side chain moieties in the polymer structure. When the pH trigger is removed, the swelling can be reversed, and this process can be continually cycled by adjusting the pH. In this work, we are leveraging this swelling–deswelling–reswelling mechanism to develop a simple, fast, and easy loading strategy for a class of cross-linked polymeric nanoparticles, poly-2-(diethylamino) ethyl methacrylate (pDEAEMA), that can reversibly swell below pH 7.3, and a dye, rhodamine B isothiocyanate (RITC), as a proof-of-concept cargo molecule while comparing to poly(methyl methacrylate) (pMMA) nanoparticles as a nonswelling control. A free radical polymerization was used to generate pDEAEMA nanoparticles at three different sizes by varying the synthesis temperature. Their pH-dependent swelling and deswelling were extensively characterized using dynamic light scattering and transmission electron microscopy, which revealed a reversible increase in size for pDEAEMA nanoparticles in acidic media, whereas pMMA nanoparticles remain constant. Following dye loading, pDEAEMA nanoparticles show significant fluorescence intensity when compared to pMMA nanoparticles, suggesting that the reversible swelling is key for successful loading. Upon acidic treatment, there is a significant decrease in the fluorescence intensity when compared to the dye-loaded nanoparticles in basic media, which could be due to dilution of the dye when released in the acidic medium solution. Interestingly, nanoparticle size had no impact on dye loading properties, suggesting that the dye molecules only go so far into the polymer nanoparticle. Additionally, confocal microscopy images reveal pDEAEMA nanoparticles with higher RITC fluorescence intensity in acidic media but a lower RITC fluorescence intensity in basic media, while pMMA nanoparticles show no differences. Together, these results showcase a size reversibility-driven cargo loading mechanism that has the potential to be applied to other beneficial cargoes and for various applications. 
    more » « less
  3. Tumor-targeted fluorescent probes in the near-infrared spectrum can provide invaluable information about the location and extent of primary and metastatic tumors during intraoperative procedures to ensure no residual tumors are left in the patient's body. Even though the first fluorescence-guided surgery was performed more than 50 years ago, it is still not accepted as a standard of care in part due to the lack of efficient and non-toxic targeted probes approved by regulatory agencies around the world. Herein, we report protease-activated cationic gelatin nanoparticles encapsulating indocyanine green (ICG) for the detection of primary breast tumors in murine models with high tumor-to-background ratios. Upon intravenous administration, these nanoprobes remain optically silent due to the energy resonance transfer among the bound ICG molecules. As the nanoprobes extravasate and are exposed to the acidic tumor microenvironment, their positive surface charges increase, facilitating cellular uptake. The internalized nanoprobes are activated upon proteolytic degradation of gelatin to allow high contrast between the tumor and normal tissue. Since both gelatin and ICG are FDA-approved for intravenous administration, this activatable nanoprobe can lead to quick clinical adoption and improve the treatment of patients undergoing image-guided cancer surgery. 
    more » « less
  4. Fluorescent dye based nanoparticles (NPs) have received increased interest due to their high brightness and stability. In fluorescence microscopy and assays, high signal to background ratios and multiple channels of... 
    more » « less
  5. Purpose . Paired-agent molecular imaging methods, which employ coadministration of an untargeted, “control” imaging agent with a targeted agent to correct for nonspecific uptake, have been demonstrated to detect 200 cancer cells in a mouse model of metastatic breast cancer. This study demonstrates that indocyanine green (ICG), which is approved for human use, is an ideal control agent for future paired-agent studies to facilitate eventual clinical translation. Methods. The kinetics of ICG were compared with a known ideal control imaging agent, IRDye-700DX-labeled antibody in both healthy and metastatic rat popliteal lymph nodes after coadministration, intradermally in the footpad. Results. The kinetics of ICG and antibody-based imaging agent in tumor-free rat lymph nodes demonstrated a strong correlation with each other ( r  = 0.98, p < 0.001 ) with a measured binding potential of −0.102 ± 0.03 at 20 min postagent injection, while the kinetics of ICG and targeted imaging agent shows significant separation in the metastatic lymph nodes. Conclusion. This study indicated a potential for microscopic sensitivity to cancer spread in sentinel lymph nodes using ICG as a control agent for antibody-based molecular imaging assays. 
    more » « less